Pierre-emmanuel E. Morange

Aix-en-provence, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 158 publications

Genomic Evidence Links Inflammation to Residual Pulmonary Vascular Obstruction and Risk of Pulmonary Embolism Recurrence.

Genomic Evidence Links Inflammation to Residual Pulmonary Vascular Obstruction and Risk of Pulmonary Embolism Recurrence.

Journal: medRxiv : the preprint server for health sciences
Published: July 17, 2026

Genetic associations with pulmonary embolism among those with a deep vein thrombosis: the INVENT Consortium.

Genetic associations with pulmonary embolism among those with a deep vein thrombosis: the INVENT Consortium.

Journal: Journal of thrombosis and haemostasis : JTH
Published: February 05, 2026

Circulating biomarkers of bronchoalveolar injury help predict the need for mechanical ventilation in patients with moderate to severe COVID-19 pneumonia: A prospective cohort study.

Circulating biomarkers of bronchoalveolar injury help predict the need for mechanical ventilation in patients with moderate to severe COVID-19 pneumonia: A prospective cohort study.

Journal: PloS one
Published: November 13, 2025

Assessment of Systematic JAK2V617F Screening in 996 Patients With Venous Thromboembolism.

Assessment of Systematic JAK2V617F Screening in 996 Patients With Venous Thromboembolism.

Journal: American journal of hematology
Published: June 26, 2025

Circulating CD34+ Cells: A New Biomarker of Residual Pulmonary Vascular Obstruction after Pulmonary Embolism.

Circulating CD34+ Cells: A New Biomarker of Residual Pulmonary Vascular Obstruction after Pulmonary Embolism.

Journal: Stem cell reviews and reports
Published: March 06, 2025

Practical guideline for major hereditary thrombophilia.

Practical guideline for major hereditary thrombophilia.

Journal: Innovation (Cambridge (Mass.))
Published: January 24, 2025

Genomic Landscape of Thrombosis Recurrence Risk Across Venous Thromboembolism Subtypes.

Genomic Landscape of Thrombosis Recurrence Risk Across Venous Thromboembolism Subtypes.

Journal: medRxiv : the preprint server for health sciences
Published: December 16, 2024

Molecular determinants of thrombosis recurrence risk across venous thromboembolism subtypes.

Molecular determinants of thrombosis recurrence risk across venous thromboembolism subtypes.

Journal: Blood
Published: December 06, 2024

Genome-Wide Search for Nonadditive Allele Effects Identifies PSKH2 as Involved in the Variability of Factor V Activity.

Genome-Wide Search for Nonadditive Allele Effects Identifies PSKH2 as Involved in the Variability of Factor V Activity.

Journal: Journal of the American Heart Association
Published: October 18, 2024

A multiomics approach reveals novel regulators of plasma factor V levels, highlighting CLEC4M as a clearance receptor.

A multiomics approach reveals novel regulators of plasma factor V levels, highlighting CLEC4M as a clearance receptor.

Journal: Blood
Published: September 20, 2024

Assessment of a next generation sequencing gene panel strategy in 133 patients with negative thrombophilia screening.

Assessment of a next generation sequencing gene panel strategy in 133 patients with negative thrombophilia screening.

Journal: Journal of thrombosis and haemostasis : JTH
Published: September 08, 2024

Impact of thrombophilia on venous thromboembolism management.

Impact of thrombophilia on venous thromboembolism management.

Journal: Presse medicale (Paris, France : 1983)
Published: September 07, 2024
Showing 1-12 of 158

Last Updated: 09/26/2026